Effect of Release of Upper Track of Deep Front Facial Line Versus Myofascial Release With IASTM on Patients With Upper Cross Syndrome (UCS)

February 10, 2026 updated by: Al Shaymaa Shaaban Abd El Azeim, Cairo University
this study will be conducted to compare the effect of release of upper track of deep front facial line versus myofascial release with IASTM on patients with Upper Cross Syndrome.

Study Overview

Detailed Description

Upper cross syndrome is a postural dysfunction that can cause a variety of upper-body musculoskeletal problems. Early detection and physiotherapy can help to prevent further complications. Maintaining bad posture over an extended duration can cause postural dysfunction and misalignment.

The first and most obvious sign of upper crossed syndrome is the characteristic postural dysfunction of protracted scapulae, medially rotated humeri, hyperkyphotic upper thoracic spine, and a protracted/ anteriorly held head, which is created by hypo lordosis or even kyphosis (excessive flexion) of the lower cervical spine, hyper lordosis of the upper cervical spine and head, and anterior translation of the head upon the atlas.

The available treatments for upper cross syndrome are Stretching, strengthening, myofascial release, postural relaxation exercise, electrical stimulations, and deep neck flexors activations are the most used techniques. Numerous studies have highlighted various benefits in terms of time efforts, and prognosis. Those are corrective exercise, Kinesio taping, scapular stabilization exercise, and PNF techniques.

Studies have demonstrated the role of fascia in various musculoskeletal dysfunctions as the fascial tissues connect the skeletal muscles forming a body-wide web in a pattern called myofascial meridians. As fascia is able to modify its tensional state, strain transmission along the meridians might occur in response to changes in muscle activity.

Deep fascia tends to be highly vascularized and contain well developed lymphatic channels. In some instances, deep fascia can even contain free encapsulated nerve endings, such as Ruffini and Pacinian corpuscles. It is present in our body in different tissue planes and in different forms with specific function and the musculoskeletal fascial system can be affected by various localized disorders with variable time course and prognosis.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Dokki
      • Giza, Dokki, Egypt, 11351
        • Alshaymaa Shaaban Abdelazeim

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 18-40 years old
  • All participants had forward head, craniovertebral angle < 50.
  • All participants had rounded back (kyphosis angle ≥ 42°)
  • Based on assessment of upper cross syndrome by photogrammetric analysis.
  • The subjects were chosen from both genders.

Exclusion Criteria:

  • History of trauma or surgery in cervical region.
  • Bone fractures or acute soft tissue injuries.
  • Osteoporosis.
  • Heart attack.
  • Unstable angina pectoris -Implanted pacemaker or defibrillator- -Cancer-
  • Rheumatoid arthritis
  • Connective tissue disease: This includes diseases such as osteomyelitis, lupus and scleroderma -Neurological conditions-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Upper Track of Deep Front Facial Line realese
Thirty subjects received release of upper track of deep front facial line in addition supervised corrective exercises three times a week for four weeks.
The MFR techniques were applied to the designated regions, with soft, steady pressure lasting 90 to 120 seconds postural correction exercises The upper track of deep front facial line release procedures were applied. Hyoid mobilization; Larynx mobilization; Sternal oscillations; and Barral's Transversus Thoracis mobilization. The thoracic inlet releasing ; intrathoracic fascia elongation; scalene releasing and diaphragm relaxation
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.
Experimental: Myofascial Release With IASTM
thirty subjects received myofascial release with IASTM in addition supervised corrective exercises three time a week for four weeks
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.
The instrument is designed to mobilize soft tissues. Facilitation approaches were employed to break apart adhesions. Emollient Gel/Lubrication Gel (Hawk Grips product) was also used to lubricate the skin and allow the instrument to move more easily. The tool has two sides: one for therapy and the other for holding plus postural correction exercises
Active Comparator: supervised corrective exercises
thirty subjects received supervised corrective exercises three time a week for four weeks
The exercise program included cervical stabilization exercises performed in 3 sets of 10 repetitions with a 10-second maintenance, scapular stabilization exercises plus stretching of cervical muscles.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neck disability
Time Frame: up to four weeks
The neck disability assessment will be performed using the Neck Disability Index (NDI) questionnaire - it contains ten items that refer to neck pain (intensity) and the level of ability to manage daily living activities (personal care, reading, lifting, headache, work, concentration, driving, sleep and recreation). The NDI score is interpreted as 0-4=no disability, 5-14=mild disability, 15-24=moderate disability, 25-34=severe disability, and over 34= total disability, where a score of 50 converted to percentiles represents 100%. NDI score is calculated as follows: total score/total possible score, transformed to percentage multiplied by 100=% points
up to four weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: up to four weeks
he subject was in a relaxed position then gave him the appendix which contains VAS. The subject was instructed to place a vertical mark on the line to indicate his/her pain. the line has two ends; one with no pain (zero) and the other extreme pain (100 mm) at the other end
up to four weeks
craniovertebral angle
Time Frame: up to four weeks
craniovertebral angle will be measured by Photogrammetry method. A CVA below 48-50 degrees indicates FHP
up to four weeks
kyphosis angle
Time Frame: up to four weeks
kyphosis angle will be measured by Photogrammetry method.
up to four weeks
upper chest expansion
Time Frame: up to four weeks
tape measurements will be used to measure upper chest expansion
up to four weeks
lower chest expansion
Time Frame: up to four weeks
ape measurements will be used to measure lower chest expansion
up to four weeks
cervical range of motion
Time Frame: up to four weeks
cervical range of motion device will be used to measure cervical range of motion
up to four weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2025

Primary Completion (Actual)

February 1, 2026

Study Completion (Actual)

February 1, 2026

Study Registration Dates

First Submitted

March 26, 2025

First Submitted That Met QC Criteria

April 1, 2025

First Posted (Actual)

April 2, 2025

Study Record Updates

Last Update Posted (Actual)

February 12, 2026

Last Update Submitted That Met QC Criteria

February 10, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Cross Syndrome

Clinical Trials on upper Track of Deep Front Facial Line realese

Subscribe